Skip to main content

Table 1 Baseline characteristics and treatment response of 158 patients with HCC

From: Arterial enhancement fraction in evaluating the therapeutic effect and survival for hepatocellular carcinoma patients treated with DEB-TACE

Characteristics

No. of patients

Median age (y)

56 (24, 84)a

Gender

 Male

137 (86.7%)

 Female

21 (13.3%)

Child-Pugh class

 A

123 (77.8%)

 B

35 (22.2%)

Cause of HCC

 Hepatitis B

136 (86.1%)

 Other

22 (13.9%)

AFP (ng/ml)

  ≤ 400

91 (57.6%)

  > 400

67 (42.4%)

No. of lesions

 Solitary

76 (48.1%)

 Multifocal

82 (51.9%)

Diameter (cm)

9.2 ± 4.2

Macrovascular invasion

 Absent

99 (62.7%)

 Present

59 (37.3%)

Treatment response

 CR

14 (8.8%)

 PR

53 (33.5%)

 SD

58 (36.7%)

 PD

33 (21.0%)

  1. Unless otherwise indicated, data in parentheses are percentages
  2. HCC Hepatocellular carcinoma, AFP α-fetoprotein, CR Complete response, PR Partial response, SD Stable disease, PD Progressive disease
  3. aData in parentheses are range